Zepteon Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • 2ndary - Private

Zepteon General Information

Description

Developer of chromatography resins designed for the separation of non-fucosylated antibodies. The company develops chromatography resins that are capable of generating highly potent antiviral biologic therapies as well as can be used analytically for rapid analysis of bioreactor conditions, enabling physicians to make biosimilar antibodies with targeted non fucose levels.

Contact Information

Website
www.zepteon.com
Ownership Status
Privately Held (backing)
Financing Status
Formerly Angel backed
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Primary Office
  • 42 Chauncy Street
  • Suite 10A
  • Boston, MA 02111-2308
  • United States
+1 (877) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zepteon Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Secondary Transaction - Private 00000 Completed Generating Revenue
1. Angel (individual) 09-Apr-2015 00000 00000 Completed Startup
To view Zepteon’s complete valuation and funding history, request access »

Zepteon Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of chromatography resins designed for the separation of non-fucosylated antibodies. The company develops chrom
Surgical Devices
Boston, MA
4 As of 2023
00000
000000 - 000 00000

000000

ur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna a
0000000000000
Zug, Switzerland
000 As of 0000
00000
000000000 00000

000000

erit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur s
0000000000000
Codolet, France
000 As of 0000
0000 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Zepteon Competitors (10)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland 000 00000 000000000 00000
000000 000000000 Formerly PE-Backed Codolet, France 000 000000&0
00000000 000000000 Formerly VC-backed Cambridge, MA 000 00000 000000 - 000 00000
00000000 000000000 Private Equity-Backed Cincinnati, OH 000 000000000000
000000000 Formerly VC-backed Paris, France 000 00000 0000
You’re viewing 5 of 10 competitors. Get the full list »

Zepteon Patents

  • 9

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

Zepteon Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2012283858-A1 Polypeptide separation methods Active 20-Jul-2011 00000000
AU-2012283858-B2 Polypeptide separation methods Active 20-Jul-2011 00000000
AU-2012283858-C1 Polypeptide separation methods Active 20-Jul-2011 00000000
CA-2842559-A1 Polypeptide separation methods Inactive 20-Jul-2011 00000000
EP-2734537-A1 Polypeptide separation methods Active 20-Jul-2011 C07K1/22 0
To view Zepteon’s complete patent history, request access »

Zepteon Executive Team (2)

Name Title Board Seat Contact Info
Austin Boesch Ph.D Co-Founder, Chief Executive Officer & Board Member
Glen Bolton Ph.D Co-Founder, Chief Operating Officer & Board Member
To view Zepteon’s complete executive team members history, request access »

Zepteon Board Members (2)

Name Representing Role Since
Austin Boesch Ph.D Zepteon Co-Founder, Chief Executive Officer & Board Member 000 0000
Glen Bolton Ph.D Zepteon Co-Founder, Chief Operating Officer & Board Member 000 0000
To view Zepteon’s complete board members history, request access »

Zepteon Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial